Microalbuminuria and Mortality in Long-Duration Type 1 Diabetes
- Kate V. Allen, MRCP and
- James D. Walker, MD
- Address correspondence and reprint requests to Dr. James D. Walker, Department of Diabetes, Royal Infirmary, Edinburgh, EH3 9YW, Scotland. E-mail: james.walker{at}luht.scot.nhs.uk
Abstract
OBJECTIVE—Microalbuminuria is a recognized risk factor for increased mortality and renal failure in type 1 diabetes. Whether it remains a powerful predictor in patients with a long duration of type 1 diabetes is not known. We ascertained the prognostic significance of abnormal urinary albumin excretion in a cohort of patients with at least 30 years of type 1 diabetes.
RESEARCH DESIGN AND METHODS—A total of 190 patients with a disease duration of type 1 diabetes of at least 30 years with baseline and 5 years of follow-up.
RESULTS—At baseline 66% were normoalbuminuric, and at 5 years 11% of this cohort had died. Of the 22% who were microalbuminuric at baseline, 26% had died, and of the 8% with persistent proteinuria at baseline, 44% had died. Of the 4% with end-stage renal failure at baseline, 71% had died within 5 years. Death was attributable to a cardiovascular cause in two-thirds of the cases in all groups.
CONCLUSIONS—Even in those with a long duration of type 1 diabetes, the presence of abnormal urinary excretion remains a powerful predictor of increased mortality.
Footnotes
-
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.
-
- Accepted May 9, 2003.
- Received November 11, 2002.
- DIABETES CARE














